Loading clinical trials...
Loading clinical trials...
The objective of this protocol is to investigate the effect of consumption of a commercially available energy drink beverage on blood pressure, heart rate, and energy metabolism
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas at Arlington
NCT07365332 · Pulmonary Arterial Hypertension
NCT07218029 · Pulmonary Arterial Hypertension
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT07244458 · Dietary Change, Obesity & Overweight, and more
UT Arlington - Science and Engineering Innovation and Research Building
Arlington, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions